Bruker Corporation (BRKR) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.

Total Cash From Operating Activities Chart for Bruker Corporation

Bruker Corporation (BRKR) operating cash flow for FY2025 was USD 134.1M, a -46.6% change from FY2024. Bruker Corporation's operating cash flow grew from USD 5.4M in 1999 to USD 134.1M in 2025 (2366.3% over 26 years). Operating cash flow compound annual growth rate: 5-year CAGR of -16.6%, 10-year CAGR of -5.2%, 20-year CAGR of 6.0%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Key Stats

Market Cap
$9.22B
Implied Share Price
$60.50
Enterprise Value
$10.69B
Revenue (TTM)
$3.50B
EBITDA
$541.10M
Profit Margin
-2.04%
Trailing P/E
—
Forward P/E
13.83
Price/Book (MRQ)
3.82
Price/Sales (TTM)
2.63
EV/EBITDA
39.72
EV/Revenue
3.06
Dividend Yield
0.31%
Book Value
$15.63
Free Cash Flow (FY2025)
$13.90M
Free Cash Flow Yield
0.15%

Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.